Success stories in genomic medicine from resource-limited countries

Human Genomics

Volumn 9, Issue 1, 2015, Pages

  Mitropoulos, Konstantinos ^a   Al Jaibeji, Hayat ^b,c   Forero, Diego A ^d   Laissue, Paul ^e   Wonkam, Ambroise ^f   Lopez Correa, Catalina ^g   Mohamed, Zahurin ^h   Chantratita, Wasun ⁱ   Lee, Ming Ta Michael ^j,k   Llerena, Adrian ^l   Brand, Angela ^b   Ali, Bassam R ^c   Patrinos, George P ^m  

^a Golden Helix Institute of Biomedical Research   (United Kingdom)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^d CENTRO DE INVESTIGACIONES   (Colombia)

^e UNIVERSIDAD DEL ROSARIO   (Colombia)

^f UNIVERSITY OF CAPE TOWN   (South Africa)

^g Genome Centre Quebec   (Canada)

^h UNIVERSITY OF MALAYA   (Malaysia)

ⁱ MAHIDOL UNIVERSITY   (Thailand)

^j Institute of Physical and Chemical Research   (Japan)

^k INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^l UNIVERSITY OF EXTREMADURA   (Spain)

^m UNIVERSITY OF PATRAS   (Greece)

more..

Author keywords

Africa; Economic evaluation in pharmacogenomics; Genetics education; Genome informatics; Genomic medicine; Latin America; Pharmacogenomics; Public health genomics; Southeast Asia

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; ECONOMIC EVALUATION; GENE MAPPING; HEALTH CARE SYSTEM; HUMAN; MEDICAL INFORMATICS; NEXT GENERATION SEQUENCING; PHARMACOGENOMICS; DEVELOPED COUNTRY; ECONOMICS; GENOMICS; HUMAN GENOME; PHARMACOGENETICS; PUBLIC HEALTH; TRANSLATIONAL RESEARCH; TRENDS;

DEVELOPED COUNTRIES; GENOME, HUMAN; GENOMICS; HUMANS; PHARMACOGENETICS; PUBLIC HEALTH; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84944895937     PISSN: 14739542     EISSN: 14797364     Source Type: Journal    
DOI: 10.1186/s40246-015-0033-3     Document Type: Article

References (57)

1. McCarthy JJ, McLeod HL, Ginsburg GS. Genomic medicine: a decade of successes, challenges, and opportunities. Sci Transl Med. 2013;5(189):189sr4.
2. Mardis ER. A decade's perspective on DNA sequencing technology. Nature. 2011;470(7333):198-203.
3. Mitropoulos K, Johnson L, Vozikis A, Patrinos GP. Relevance of pharmacogenomics for developing countries in Europe. Drug Metabol Drug Interact. 2011;26(4):143-6.
4. Giardine B, Borg J, Higgs DR, Peterson KR, Philipsen S, Maglott D, et al. Systematic documentation and analysis of human genetic variation in hemoglobinopathies using the microattribution approach. Nat Genet. 2011;43(4):295-301.
5. Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, et al. Medical genetics: a marker for Stevens-Johnson syndrome. Nature. 2004;428(6982):486.
6. ∗5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci USA. 2005;102(11):4134-9.
7. ∗1502 screening in Taiwan. N Engl J Med. 2011;364(12):1126-33.
8. Dalabira E, Viennas E, Daki E, Komianou A, Bartsakoulia M, Poulas K, et al. DruGeVar: an online resource triangulating drugs with genes and genomic biomarkers for clinical pharmacogenomics. Public Health Genomics. 2014;17(5-6):265-71.
9. Borchers AT, Lee JL, Naguwa SM, Cheema GS, Gershwin ME. Stevens-Johnson syndrome and toxic epidermal necrolysis. Autoimmun Rev. 2008;7(8):598-605.
10. Niemz A, Ferguson TM, Boyle DS. Point-of-care nucleic acid testing for infectious diseases. Trends Biotechnol. 2011;29(5):240-50.
11. Sirugo G, Hennig BJ, Adeyemo AA, Matimba A, Newport MJ, Ibrahim ME, et al. Genetic studies of African populations: an overview on disease susceptibility and response to vaccines and therapeutics. Hum Genet. 2008;123(6):557-98.
12. Dandara C, Swart M, Mpeta B, Wonkam A, Masimirembwa C. Cytochrome P450 pharmacogenetics in African populations: implications for public health. Expert Opin Drug Metab Toxicol. 2014;10(6):769-85.
13. Bayoumi RA, Nur-E-Kamal MS, Tadayyon M, Mohamed KK, Mahboob BH, Qureshi MM, et al. Molecular characterization of erythrocyte glucose-6-phosphate dehydrogenase deficiency in Al-Ain District, United Arab Emirates. Hum Hered. 1996;46(3):136-41.
14. Woolhouse NM, Qureshi MM, Bastaki SM, Patel M, Abdulrazzaq Y, Bayoumi RA. Polymorphic N-acetyltransferase (NAT2) genotyping of Emiratis. Pharmacogenetics. 1997;7(1):73-82.
15. Qumsieh RY, Ali BR, Abdulrazzaq YM, Osman O, Akawi NA, Bastaki SM. Identification of new alleles and the determination of alleles and genotypes frequencies at the CYP2D6 gene in Emiratis. PloS One. 2011;6(12):e28943.
16. Fortina P, Al Khaja N, Al Ali MT, Hamzeh AR, Nair P, Innocenti F, et al. Genomics into healthcare: the 5th Pan Arab Human Genetics Conference and 2013 Golden Helix Symposium. Hum Mutat. 2014;35(5):637-40.
17. Abu Dhabi HAA. Reporting adverse reaction. http://www.haad.ae/haad. Accessed 29-Mar-2015.
18. Mitropoulou C, Mai Y, Van Schaik RH, Vozikis A, Patrinos GP. Stakeholder analysis in pharmacogenomics and genomic medicine in Greece. Public Health Genomics. 2014;17(5-6):280-6.
19. Reydon TA, Kampourakis K, Patrinos GP. Genetics, genomics and society: the responsibilities of scientists for science communication and education. Personalized Medicine. 2012;9(6):633-43
20. Syurina E, Brankovic I, Probst-Hensch N, Brand A. Genome-based health literacy: a new challenge for public health genomics. Public Health Genomics. 2011;14 (4-5) 201-10
21. Pisanu C, Tsermpini EE, Mavroidi E, Katsila T, Patrinos GP, Squassina A. Assessment of the pharmacogenomics educational environment in Southeast Europe. Public Health Genomics. 2014;17 (5-6) 272-9.
22. Mai Y, Mitropoulou C, Papadopoulou XE, Vozikis A, Cooper DN, Van Schaik RH, et al. Critical appraisal of the views of healthcare professionals with respect to pharmacogenomics and personalized medicine in Greece. Personalized Medicine. 2014;11(1):15-26.
23. Palacios R, Collado-Vides J. Development of genomic sciences in Mexico: a good start and a long way to go. PLoS Comput Biol. 2007;3(9):1670-3
24. Wonkam A, Njamnshi AK, Angwafo 3rd FF. Knowledge and attitudes concerning medical genetics amongst physicians and medical students in Cameroon (sub-Saharan Africa). Genet Med. 2006;8(6):331-8.
25. Wonkam A, Hurst S. A call for policy action in sub-Saharan Africa to rethink diagnostics for pregnancy affected by sickle cell disease: differential views of medical doctors, parents and adult patients predict value conflicts in Cameroon. OMICS. 2014;18 (7) 472-80.
26. Mercier S, Küry S, Shaboodien G, Houniet DT, Khumalo NP, Bou-Hanna C, et al. Mutations in FAM111B cause hereditary fibrosing poikiloderma with tendon contracture, myopathy, and pulmonary fibrosis. Am J Hum Genet. 2013;93(6):1100-7.
27. Mtatiro SN, Singh T, Rooks H, Mgaya J, Mariki H, Soka D, et al. Genome wide association study of fetal hemoglobin in sickle cell anemia in Tanzania. PloS One. 2014;9(11):e111464.
28. Wonkam A, Ngo Bitoungui VJ, Vorster AA, Ramesar R, Cooper RS, Tayo B, et al. Association of variants at BCL11A and HBS1L-MYB with hemoglobin F and hospitalization rates among sickle cell patients in Cameroon. PloS One. 2014;9(3):e92506.
29. Wonkam A. Letter to the editor regarding "GJB2, GJB6 or GJA1 genes should not be investigated in routine in non syndromic deafness in people of sub-Saharan African descent". Int J Pediatr Otorhinolaryngol 2015;79(4):632-3.
30. Tekola Ayele F, Adeyemo A, Finan C, Hailu E, Sinnott P, Burlinson ND, et al HLA class II locus and susceptibility to podoconiosis. N Engl J Med. 2012;366(13):1200-8.
31. Beighton P, Fieggen K, Wonkam A, Ramesar R, Greenberg J. UCT's contribution to medical genetics in Africa - from the past into the future. South African medical journal (Suid-Afrikaanse tydskrif vir geneeskunde). 2012;102 (6) 446-8.
32. Chaabouni-Bouhamed H. Tunisia: communities and community genetics. Community Genet. 2008;11 (6) 313-23
33. El-Beshlawy A, El-Shekha A, Momtaz M, Said F, Hamdy M, Osman O, et al Prenatal diagnosis for thalassaemia in Egypt: what changed parents' attitude? Prenat Diagn. 2012;32(8):777-82.
34. Wonkam A, Tekendo CN, Sama DJ, Zambo H, Dahoun S, Béna F, et al. Initiation of a medical genetics service in sub-Saharan Africa: experience of prenatal diagnosis in Cameroon. Eur J Med Genet. 2011;54(4):e399-404.
35. Pepper MS. Launch of the Southern African Human Genome Programme. South African medical journal (Suid-Afrikaanse tydskrif vir geneeskunde). 2011;101 (5) 287-8.
36. H3Africa Consortium, Rotimi C, Abayomi A, Abimiku A, Adabayeri VM, Adebamowo C, et al. Research capacity. Enabling the genomic revolution in Africa. Science. 2014 344(6190):1346-8.
37. Gurdasani D, Carstensen T, Tekola-Ayele F, Pagani L, Tachmazidou I, Hatzikotoulas K, et al. The African Genome Variation Project shapes medical genetics in Africa. Nature. 2015;517 (7534) 327-32.
38. Ruiz-Linares A, Adhikari K, Acuña-Alonzo V, Quinto-Sanchez M, Jaramillo C, Arias W, et al. Admixture in Latin America: geographic structure, phenotypic diversity and self-perception of ancestry based on 7, 342 individuals. PLoS Genet. 2014;10(9):e1004572
39. Jimenez-Sanchez G, Silva-Zolezzi I, Hidalgo A, March S. Genomic medicine in Mexico: initial steps and the road ahead. Genome Res. 2008;18(8):1191-8.
40. Silva-Zolezzi I, Hidalgo-Miranda A, Estrada-Gil J, Fernandez-Lopez JC, Uribe-Figueroa L, Contreras A, et al. Analysis of genomic diversity in Mexican Mestizo populations to develop genomic medicine in Mexico. Proc Natl Acad Sci USA. 2009;106(21):8611-6.
41. Moreno-Estrada A, Gignoux CR, Fernández-López JC, Zakharia F, Sikora M, Contreras AV, et al. The genetics of Mexico recapitulates Native American substructure and affects biomedical traits. Science. 2014;344(6189):1280-5.
42. Passos-Bueno MR, Bertola D, Horovitz DD, De Faria Ferraz VE, Brito LA. Genetics and genomics in Brazil: a promising future. Mol Genet Genomic Med. 2014;2(4):280-91.
43. Ortega-Recalde O, Vergara JI, Fonseca DJ, Ríos X, Mosquera H, Bermúdez OM, et al. Whole-exome sequencing enables rapid determination of xeroderma pigmentosum molecular etiology. PloS One. 2014;8(6):e64692.
44. Pinto WB, Oliveira AS, Souza PV. Whole exome sequencing identifies three recessive FIG 4-mutations in an apparently dominant pedigree with Charcot-Marie-Tooth disease. Neuromuscul Disord. 2015;25(4):359-60.
45. Benitez BA, Forero DA, Arboleda GH, Granados LA, Yunis JJ, Fernandez W, et al. Exploration of genetic susceptibility factors for Parkinson's disease in a South American sample. J Genet. 2010;89(2):229-32.
46. Hodges E, Xuan Z, Balija V, Kramer M, Molla MN, Smith SW, et al. Genomewide in situ exon capture for selective resequencing. Nat Genet. 2007;39(12):1522-7.
47. Albert TJ, Molla MN, Muzny DM, Nazareth L, Wheeler D, Song X, et al. Direct selection of human genomic loci by microarray hybridization. Nat Methods. 2007;4(11):903-5.
48. Shendure J, Ji H. Next-generation DNA sequencing. Nat Biotechnol. 2008;26(10):1135-45.
49. Gnirke A, Melnikov A, Maguire J, Rogov P, LeProust EM, Brockman W, et al. Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat Biotechnol. 2009;27(2):182-9.
50. Diggle CP, Parry DA, Logan CV, Laissue P, Rivera C, Restrepo CM, et al. Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis. Hum Mutat. 2012;33(8):1175-81.
51. Prada CF, Laissue P. A high resolution map of mammalian X chromosome fragile regions assessed by large-scale comparative genomics. Mamm Genome. 2014;25(11-12):618-35.
52. Snyder SR, Mitropoulou C, Patrinos GP, Williams MS. Economic evaluation of pharmacogenomics: a value-based approach to pragmatic decision making in the face of complexity. Public Health Genomics. 2014;17(5-6):256-64.
53. ∗15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand. Epilepsia. 2013;54(9):1628-38.
54. Grosse SD. Assessing cost-effectiveness in healthcare: history of the $50, 000 per QALY threshold. Expert Rev Pharmacoecon Outcomes Res. 2008;8(2):165-78.
55. ∗1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore. Neurology. 2012;79(12):1259-67.
56. Mitropoulou C, Fragoulakis V, Bozina N, Vozikis A, Supe S, Bozina T, et al. Economic evaluation of pharmacogenomic-guided warfarin treatment for elderly Croatian atrial fibrillation patients with ischemic stroke. Pharmacogenomics. 2015;16(2):137-48.
57. Cooper DN, Brand A, Dolzan V, Fortina P, Innocenti F, Lee MT, et al. Bridging genomics research between developed and developing countries: the Genomic Medicine Alliance. Per Med. 2014;11(7):615-23.